Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oncolytics Biotech, Inc.

http://www.oncolyticsbiotech.com

Latest From Oncolytics Biotech, Inc.

Gilead Adds Inflammation Targets To Its 2020 R&D Collaboration With Arcus

Deal Snapshot: Already partnered on an anti-TIGIT drug and other immuno-oncology candidates, the firms will team up further on four targets in inflammatory disease.

Deals Business Strategies

Time To Grow: SK Bioscience Eyes US Vaccine, CGT Acquisitions This Year

SK Bioscience CEO outlines the progress the firm is making in its growth acceleration strategy, which involves aggressive M&As and other investment plans.

South Korea Commercial

Finance Watch: Lucky Few Raise Cash While Many Public Biotechs Cut Costs

Public Company Edition: ImmunoGen received the first $75m under a $175m term loan, while Protagonist raised $100m in a follow-on offering, but companies with bankruptcy filings and job cuts outpaced those accessing new capital by a wide margin in late March and early April.

Financing Restructuring

$435m Impairment Loss Hits Astellas As Evrenzo Falters, Asset, Deal Dropped

Japanese major’s profit figures for fiscal year just ended will be hit by multiple accounting decisions related to sales, pipeline and partnerships.

Commercial Regenerative Medicine
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register